Get the latest tech news
CRISPR Gene-Editing Being Offered To British Blood Disorder Patients
The first therapy that uses gene-editing is to be offered on the NHS in a "revolutionary breakthrough" for patients. From a report: It will be used as a potential cure for the blood disorder beta thalassaemia. Stem cells which make blood will be extracted, reprogrammed to correct the condition and r...
Stem cells which make blood will be extracted, reprogrammed to correct the condition and returned to the patient's body. People with beta thalassaemia struggle to produce enough haemoglobin, which is the protein in red blood cells that carries oxygen around the body. It can leave people severely tired, weak, and short of breath and also cuts life expectancy.
Or read this on Slashdot
